Crossmark

Solid component tumor doubling time is a prognostic factor in non-small cell lung cancer patients

Crossref DOI link: https://doi.org/10.1186/s13019-019-0879-x

Published Online: 2019-03-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Miura, Kentaro

Hamanaka, Kazutoshi

Koizumi, Tomonobu

Kawakami, Satoshi

Kobayashi, Nobutaka

Ito, Ken-ichi
License Information

Text and Data Mining valid from 2019-03-12
More Information

Article History

Received: 21 November 2018

Accepted: 4 March 2019

First Online: 12 March 2019

Ethics approval and consent to participate

: This study was approved by our institution’s research ethics committee (No. 3395).

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.